Jump to main content
博士論文

Combination treatment of human pancreatic cancer xenograft models with the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib and oncolytic herpes simplex virus HF10

Icons representing 博士論文
The cover of this title could differ from library to library. Link to Help Page

Combination treatment of human pancreatic cancer xenograft models with the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib and oncolytic herpes simplex virus HF10

Persistent ID (NDL)
info:ndljp/pid/8699204
Material type
博士論文
Author
山村, 和生
Publisher
山村, 和生
Publication date
2014
Material Format
Digital
Capacity, size, etc.
-
Name of awarding university/degree
名古屋大学,博士(医学)
View All

Notes on use at the National Diet Library

本資料は、掲載誌(URI)等のリンク先にある学位授与機関のWebサイトやCiNii DissertationsLeave the NDL website. から、本文を自由に閲覧できる場合があります。

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Digital

Material Type
博士論文
Author/Editor
山村, 和生
Publication, Distribution, etc.
Publication Date
2014
Publication Date (W3CDTF)
2014
Alternative Title
ヒト膵癌異種移植モデルにおける上皮成長因子受容体チロシンキナーゼ阻害薬エルロチニブと腫瘍溶解性単純ヘルペスウイルスHF10との併用療法
Degree grantor/type
名古屋大学
Date Granted
2014-03-25
Date Granted (W3CDTF)
2014-03-25